Literature DB >> 9648121

Multiple sclerosis and infectious childhood diseases.

S Bachmann1, J Kesselring.   

Abstract

To examine a possible relationship between infectious diseases and multiple sclerosis (MS) an enquiry was carried out among 606 MS patients in Switzerland. The data concerning their infectious childhood diseases were compared with epidemiological data for the normal Swiss population obtained from the Swiss Federal Health Office and from the Institute of Medical Statistics. The mean age of the MS patients was 50.7 years and the mean age at onset of multiple sclerosis was 33.8 years, significantly earlier in women (33.2 years) than in men (35.4 years, p < 0.05). In 18.8% multiple members of the family were affected. In comparison with persons of the control population, MS patients had measles infection at a later age (6.4 vs. 7.5 years). The curve of the age at which several infectious childhood diseases occurred was shifted to higher ages for MS patients (p < 0.005) compared to normal controls for mumps (80.2% for MS vs. 64.1% for controls in the age group 5-14 years), rubella (64.3% for MS vs. 48.4% for controls in the age group 5-14 years) and varicella (81.9% for MS vs. 39.0% for controls in the age group 5-19 years). For pertussis, however, there were more cases among those who later developed MS in the age group 1-9 years, which was earlier than in controls (86.0 vs. 56.7%). These results are compatible with the hypothesis that the risk of developing multiple sclerosis may be associated with acquiring certain infectious childhood diseases at a later stage in comparison to normal controls.

Entities:  

Mesh:

Year:  1998        PMID: 9648121     DOI: 10.1159/000026167

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  8 in total

1.  Epstein-Barr virus and disease activity in multiple sclerosis.

Authors:  D Buljevac; G J J van Doornum; H Z Flach; J Groen; A D M E Osterhaus; W Hop; P A van Doorn; F G A van der Meché; R Q Hintzen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

2.  A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk.

Authors:  Cecilia Ahlgren; Kjell Torén; Anders Odén; Oluf Andersen
Journal:  Eur J Epidemiol       Date:  2009-07-26       Impact factor: 8.082

3.  Environmental exposures and the risk of multiple sclerosis in Saudi Arabia.

Authors:  Osama Al Wutayd; Ashri Gad Mohamed; Jameelah Saeedi; Hessa Al Otaibi; Mohammed Al Jumah
Journal:  BMC Neurol       Date:  2018-06-19       Impact factor: 2.474

Review 4.  Herpesviruses--a rationale for antiviral treatment in multiple sclerosis.

Authors:  T Bergström
Journal:  Antiviral Res       Date:  1999-02       Impact factor: 5.970

5.  Detection of mumps virus RNA in cerebrospinal fluid of patients with neuromyelitis optica.

Authors:  Masahiro Mori; Mitsuaki Hosoya; Takaki Hiwasa; Sei Hayakawa; Akiyuki Uzawa; Satoshi Kuwabara
Journal:  Neurol Sci       Date:  2011-04-06       Impact factor: 3.307

6.  The High Prevalence of the Varicella Zoster Virus in Patients With Relapsing-Remitting Multiple Sclerosis: A Case-Control Study in the North of Iran.

Authors:  Saeideh Najafi; Masood Ghane; Shahrokh Yousefzadeh-Chabok; Mehdi Amiri
Journal:  Jundishapur J Microbiol       Date:  2016-03-12       Impact factor: 0.747

7.  The environmental risk factors in multiple sclerosis susceptibility: A case-control study.

Authors:  Vahid Shaygannejad; Nooshin Rezaie; Zamzam Paknahad; Freshteh Ashtari; Helia Maghzi
Journal:  Adv Biomed Res       Date:  2016-06-08

Review 8.  Pertussis in Individuals with Co-morbidities: A Systematic Review.

Authors:  Denis Macina; Keith E Evans
Journal:  Infect Dis Ther       Date:  2021-06-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.